Published literature has shown increased resistance to NK cell-mediated lysis due to MHC-class I upregulation in some cancers (9, 10), but increased sensitivity to NK cell-mediated lysis due to ICAM-1 upregulation in others (11, 12). This evidence concerns the gene ICAM1 and cancer.